Compare Arkham (ARKM) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Arkham vs Enzyme — how do they compare? Arkham trades at Rp1,650 (market cap Rp371,47M, Rp1,08T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Arkham is far larger — about 2.8× Enzyme's market cap, and Arkham's supply is capped (225,1M / 1B ARKM (23%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Arkham for 51 Days and Enzyme for 29 Days on average.
| ARKM | MLN | |
|---|---|---|
Market Cap | Rp371,47M | Rp134,13M |
Volume (24h) | Rp1,08T | Rp104,56M |
Circulating Supply | 225,1M / 1B ARKM (23%) | 3,3M MLN |
Typical Hold Time | 51 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKM is trading at Rp1,669, showing a bearish technical outlook with moving averages signaling strong selling pressure and oscillators neutral. The current price is near the pivot point of Rp1,670, with immediate support at Rp1,641 and resistance at Rp1,698. No major protocol updates or ecosystem developments were noted recently, with a circulating supply of 225.1 million ARKM out of a 1 million max supply, indicating a 23% circulation rate.
The overall outlook is cautious due to bearish technical signals and limited fundamental catalysts. Key opportunities include potential rebounds from support levels, but risks involve high volatility, low liquidity, and regulatory uncertainties in the crypto space. Investors should monitor trading volume and on-chain activity for signs of recovery.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Arkham
Arkham is a blockchain analysis platform that uses artificial intelligence to deanonymize the blockchain and on-chain data. Arkham’s platform can be used for various purposes, such as tracking stolen funds, identifying fraudsters, verifying counterparties, auditing transactions, investigating hacks, and more. Arkham claims its platform can help combat the proliferation of crypto crimes and scams by incentivizing on-chain research.
Read more on ARKM →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
